CVR 33358008Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København VFounded 1 Dec 2010
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Shire Biotech Denmark ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2018
Result
+860.3K
DKK, annual report 2017
Equity
3.2M
DKK, annual report 2017
Shire Denmark A/SCVR 36392290, 100% of capital and votes, until 1 Apr 2018
Kerstin Anna-Lena Engvalluntil 1 Apr 2018
No current owner is registered.
CVR 36392290100% of capital and votes26 Mar 2018 to 1 Apr 2018
100% of capital and votes7 Dec 2010 to 26 Mar 2018
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Mar 2018, monthly: 10 employees, 9 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 4 | 4 | 5 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 8 | 8 | 7 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 10 |
| FTE | 2 | 4 | 4 | 6 | 8 | 7 | 8 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 8 | 7 | 7 | 7 | 7 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 |
| Series | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Mar 2018, published 22 May 2018.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2017, DKK: Gross profit not reported, Operating profit 1.1M, Result for the year 860.3K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2017, DKK: Total assets 9.9M, Equity 3.2M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|
| Gross profit | 4,753 | 7,151 | 9,706 | 9,117 | Not reported |
| Operating profit | +377 | +598 | +950 | +1,030 | +1,128 |
| Result for the year | +232 | +343 | +669 | +776 | +860 |
| Equity | 561 | 903 | 1,572 | 2,347 | 3,208 |
| Total assets | 4,584 | 3,823 | 4,444 | 7,838 | 9,913 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 9 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 14.7% | 50.5% | 35.7% | -6.1% | Not reportednote 1 |
| EBITDA | 389 | 610 | 1,014 | 1,099 | 1,188 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | 12.5% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 0note 3 | 0note 3 | 198note 3 | 0note 3 | 0note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Shire Biotech Denmark ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 80,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
18 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 01.04.2018 opløst ved fusion med CVR-nummer: 36392290 Shire Denmark A/S.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 36392290 Shire Denmark A/S (fortsættende) og CVR-nummer: 33358008 Shire Biotech Denmark ApS (ophørende).
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 36392290 Shire Denmark A/S og CVR-nummer: 33358008 Shire Biotech Denmark ApS må antages at være tilstrækkeligt sikrede efter fusionen.
Vedtægter ændret: 01.08.2017
Nyt navn: Shire Biotech Denmark ApS
Slettet binavn: Shire Biotech Denmark ApS
Direktion:
Fratrådte:
Paul Michael Blanchfield, den 29.05.2017.
Tiltrådte:
Kerstin Anna-Lena Engvall (adm. dir), den 29.05.2017.
Ny adresse: Havneholmen 29, 1561 København V
Ny kommune: København
Ny adresse: Tobaksvejen 2A, 2860 Søborg
Ny kommune: Gladsaxe
Vedtægter ændret: 25.04.2017
Nyt binavn: Shire Biotech Denmark ApS
Bestyrelse:
Fratrådte:
Amanda Miller, den 21.04.2017, Helen Alice Lillistone, den 21.04.2017, Paul Michael Blanchfield, den 21.04.2017.
Tiltrådte:
Jacob Fredrik Westin, den 21.04.2017, Johan Åke Östen Pettersson, den 21.04.2017, Kerstin Anna-Lena Engvall (formand), den 21.04.2017.
Direktion:
Fratrådte:
.
CVR-nummer:
33358008.
NAVN:
SHIRE DENMARK ApS.
Adresse: Havneholmen 29, 1561 København V.
Kommune: København.
Bestyrelse:
Fratrådte:
Helen Rosemary Janaway, den 27.04.2015, John Erik Mattias Bankel, den 27.04.2015.
Tiltrådte:
Jasper Sökeland, den 27.04.2015, Paul Michael Blanchfield, den 27.04.2015.
Direktion:
Fratrådte:
John Erik Mattias Bankel, den 27.04.2015.
Tiltrådte:
Paul Michael Blanchfield, den 27.04.2015.
Bestyrelse:
Udtrådt af bestyrelsen:
Michael Thomas Garry, den 08.04.2014.
Indtrådt i bestyrelsen:
Helen Rosemary Janaway, den 08.04.2014.
Bestyrelse:
Udtrådt af bestyrelsen:
Mary Christine Di Marzio, den 04.12.2013.
Indtrådt i bestyrelsen:
John Erik Mattias Bankel, den 04.12.2013.
Direktion:
Udtrådt af direktionen:
Mary Christine Di Marzio, den 04.12.2013.
Indtrådt i direktionen:
John Erik Mattias Bankel, den 04.12.2013.
Revision:
Udtrådt af revisionen:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 22.05.2012.
Indtrådt i revisionen:
CVR-NR. 33963556 DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Weidekampsgade 6, 2300 København S, den 22.05.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Lars Eric Jernestahl, den 03.02.2012.
Indtrådt i bestyrelsen:
Mary Christine Di Marzio, den 03.02.2012.
Direktion:
Udtrådt af direktionen:
Lars Eric Jernestahl, den 03.02.2012.
Indtrådt i direktionen:
Mary Christine Di Marzio, den 03.02.2012.
Ny adresse:
Havneholmen 29, 1561 København V.
Revision:
Udtrådt af revisionen:
CVR-NR. 29794030 BDO KOMMUNERNES REVISION, GODKENDT REVISIONSAKTIESELSKAB, den 09.12.2010.
Indtrådt i revisionen:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Havneholmen 29, 1., 1561 København V, den 09.12.2010.
Vedtægter ændret:
09.12.2010.
Nyt navn:
SHIRE DENMARK ApS.
Bestyrelse:
Indtrådt i bestyrelsen:
Michael Thomas Garry, den 09.12.2010, Lars Eric Jernestahl, den 09.12.2010, Helen Alice Lillistone, den 09.12.2010.
Direktion:
Udtrådt af direktionen:
Peter Andreas Stakemann, den 09.12.2010.
Indtrådt i direktionen:
Lars Eric Jernestahl, den 09.12.2010.
Selskabet tegnes af direktøren eller af et bestyrelsesmedlem alene.
Revision:
Indtrådt i revisionen:
CVR-NR. 29794030 BDO KOMMUNERNES REVISION, GODKENDT REVISIONSAKTIESELSKAB, Havneholmen 29, 1561 København V, den 09.12.2010.
Stiftelsesdato:
01.12.2010.
Seneste vedtægtsdato:
01.12.2010.
Kapital:
kr. 80.000,00.
Indbetalingsmåde:
kontant kr. 80.000,00 til kurs 100,00.
Stifter:
CVR-NR. 13469938 AKTIESELSKABET STAKEMANN, Kronprinsessegade 18, 1306 København K, den 01.12.2010.
Direktion:
Advokat Peter Andreas Stakemann, den 01.12.2010.
Selskabet tegnes af en direktør.
Første regnskabsår:
01.12.2010 - 31.12.2011.
Regnskabsår:
01.01 - 31.12.
P-number 1016482540Havneholmen 29, 1561 København V